Clinical Trial Update: Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a glucagon-like peptide-1 receptor agonist as neuroprotection after endovascular treatment in acute ischemic stroke due to large vessel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Vessel Occlusion
• Stroke

Drugs mentioned

• Glucagon-like peptide-1 receptor agonist

Snippet

Sponsor: Wei Hu | Conditions: Acute Ischemic Stroke, Large Vessel Occlusion | Phase 3 | Status: NOT_YET_RECRUITING